About Us

About Biozipcode Group

“Curing the Incurable, Inspiring Global Innovation”

The Biozipcode Group is a project team led by Biozipcode, Inc. (Japan), composed of multiple affiliated companies and institutions involved in medical research, pharmaceutical development, business implementation, international collaboration, and token operations.

Research and development are carried out in partnership with academic institutions in Japan, while manufacturing and implementation are handled by partner companies in the UAE, Japan, the United States, and Palau. The token is issued by Auring Inc., a corporation registered in the British Virgin Islands (BVI).

Vision and Mission

Our mission is to redefine what’s possible in global healthcare—by proving a cure for diabetes, building resilient local economies through medical tourism, and pioneering side-effect-free therapies with Biozipcode™ technology.

Teams & Partners

Global Partners Driving the Future of Diabetes Cure

A united network of innovators, researchers, and industry leaders working together to make “cure” the new standard in diabetes care.

History

From Discovery to Breakthrough: The Journey to a Diabetes Cure

Tracing the path from the identification of diabetes stem cells to pioneering targeted treatments—our history is one of persistence, innovation, and a shared mission to make “cure” the global standard.

Community

Your Voice, Your Impact, Our Cure

Share ideas, join discussions, and collaborate with a community committed to transforming diabetes care worldwide.

Unlock the Cure Economy.

Join the GDT ICO and shape the future of global health.